Healthy ETFs
The risks and rewards that investors face when making investment decisions often can lead to more volatility than expected. This concept applies to the biotechnology sector, where the U.S. Food & Drug Administration’s approval can determine a company’s profits and, by extension, its stock price. Investors who bet on the right biotech horse can reap … Continued